Environmental Shedding of MRSA Far Greater Than From Multidrug-Resistant Gram-Negative Bacilli
By Richard R. Watkins, MD, MS, FACP, FIDSA, FISAC
Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH
SYNOPSIS: An observational cohort study showed shedding of methicillin-resistant Staphylococcus aureus by colonized patients outside hospital rooms or during outpatient clinic visits occurred more often than in those colonized by multidrug-resistant gram-negative bacilli.
SOURCE: Alhmidi H, Cadnum JL, Koganti S, et al. Shedding of methicillin-resistant Staphylococcus aureus and multidrug-resistant gram-negative bacilli during outpatient appointments and procedures outside hospital rooms. Am J Infect Control 2021;49:991-994.
Patients colonized with pathogenic bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) or multidrug-resistant gram-negative bacilli (MDR-GNB), are known to shed these organisms in their hospital rooms and during procedures. This leads to contamination of other people, environmental surfaces, and medical equipment. However, less is known about bacterial shedding outside patient rooms, such as at outpatient clinics, during physical therapy appointments, and in the radiology department. Alhmidi et al examined environmental shedding of MRSA and MDR-GNB by colonized patients in settings outside hospital rooms.
This was an observational cohort study that included patients in contact precautions for MDR-GNB or MRSA. MDR-GNB were defined as an extended-spectrum beta-lactamase (ESBL)-producing GNB or a carbapenem-resistant GNB. A control group of 10 patients with no history of MRSA or MDR-GNB colonization and with negative baseline cultures also was included. Culture swabs were obtained of the anterior nares to determine MRSA colonization and from the skin and perirectal area for patients with MDR-GNB. Environmental shedding was assessed outside patient rooms for inpatients and during outpatient clinic visits within three months of hospital discharge. Investigators cleaned and disinfected environmental surfaces. Immediately after appointments, they used culture plates to recover MRSA or MDR-GNB from a standardized group of high-touch surfaces. For the first 10 appointments, they collected cultures before patients entered the room to ensure no MRSA or MDR-GNB were recoverable. For patients known to be colonized with MRSA, spa typing was performed on environmental isolates. These were considered to be concordant with nares isolates if the spa type was the same. In those with MDR-GNB colonization, environmental isolates were considered concordant if the perirectal or skin isolates had the same species identification and susceptibility pattern.
There were 39 patients with MRSA colonization and 11 with MDR-GNB included in the study. The frequency of environmental shedding was significantly greater for MRSA (38%) vs. MDR-GNB (0%; P = 0.02). No MRSA or MDR-GNB were recovered from the 10 control patients. Following two outpatient appointments with MRSA-colonized patients, contamination was detected in the provider work area after a provider’s hands contacted a patient without wearing gloves and did not perform hand hygiene. Spa typing was performed on 10 MRSA carriers, of whom eight had the same nasal and environmental isolates identified. Finally, the presence of a wound that was culture-positive for MRSA was the only significant characteristic associated with shedding.
COMMENTARY
The study by Alhmidi et al demonstrates the high frequency of MRSA shedding into the environment by colonized patients, particularly those with MRSA in their wounds. This provides strong evidence of the need for effective environmental decontamination in outpatient clinics and other sites where inpatient appointments occur, such as physical therapy, to reduce MRSA transmission. It also supports implementing other methods that might lead to less MRSA shedding, such as chlorhexidine bathing, patient hand hygiene, and the use of intranasal mupirocin.
Of equal importance was the finding that MDR-GNB colonization did not lead to similar environmental shedding. This calls into question the appropriateness of contact isolation for patients colonized with MDR-GNB. Contact precautions carry several potential downsides, including patient dissatisfaction caused by less interaction with hospital staff, higher hospital costs (e.g., isolation gowns and gloves), and restricted visitation. These must be weighed against the potential of transmission of pathogenic bacteria to vulnerable patients, staff, and objects in the environment, such as medical equipment. Although the results of the study are reassuring in terms of the low risk of MDR-GNB shedding, further research is necessary to replicate this finding.
There were a few limitations. First, the study was conducted at a single Veterans Affairs hospital, so the population almost entirely was older men. Thus, the results might not be generalizable to other groups. Second, there was a relatively small number (n = 11) of patients colonized with MDR-GNB. Third, 20% of the MRSA isolates featured spa types different from concurrent nasal isolates, which raises the possibility some MRSA isolates originated from healthcare workers or another source. Finally, healthcare workers were aware they were under observation. MRSA shedding can occur in other areas besides inpatient rooms. This has important policy ramifications for infection control personnel in their efforts to reduce the transmission of MRSA in healthcare facilities. Fortunately, the risk of transmission of MDR-GNB by colonized patients shedding into the environment appears to be much lower.
An observational cohort study showed shedding of methicillin-resistant Staphylococcus aureus by colonized patients outside hospital rooms or during outpatient clinic visits occurred more often than in those colonized by multidrug-resistant gram-negative bacilli.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.